The advent of Human Menopausal Gonadotropin【 Kang Yuan】

　　Since the advent of Human Menopausal Gonadotropin (hMG) in the 1960s, it has been widely used in the treatment of human infertility. Since then, it has become the mainstream of infertility treatment worldwide for 20 years. The ratio of follicle-stimulating hormone (FSH) to luteinizing hormone (LH) in Human Menopausal Gonadotropin is 1:1. hMG has been used in my country for many years and can be used independently as a drug for ovulation induction therapy. It is generally used in infertile women who fail to use clomiphene as first-line treatment for ovulatory dysfunction; it is also used in patients with hypogonadotropic hypogonadism. Both men and women; are also widely used in women undergoing controlled ovarian hyperstimulation (COH) for invitro fertilization (IVF). A large number of clinical practices have proved the effectiveness and safety of hMG.

　　Kangyuan Corporation is a raw material manufacturer that supplies a variety of raw materials, including

　　Human chorionic gonadotropin, Human Menopausal Gonadotropin, Urofollitropin, Urokinase, Hormone API, etc. We have many years of experience in production and R&D. If you have any needs in this regard, you can directly contact Kangyuan by phone, and we will serve you wholeheartedly.